Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» EyeGate Pharma Secures $22M In Series D Venture Funding For Continued Development Of EGP-437 For Dry Eye Syndrome
EyeGate Pharma Secures $22M In Series D Venture Funding For Continued Development Of EGP-437 For Dry Eye Syndrome
EyeGate Pharma Secures $22M In Series D Venture Funding For Continued Development Of EGP-437 For Dry Eye Syndrome
Submitted by
admin
on January 10, 2010 - 11:48am
Source:
Medical News Today
News Tags:
EyeGate Pharma
dry eye disease
Headline:
EyeGate Pharma Secures $22M In Series D Venture Funding For Continued Development Of EGP-437 For Dry Eye Syndrome
Do Not Allow Advertisers to Use My Personal information
